TY - JOUR
T1 - Temporal Trends in Cardiovascular Complications in People With or Without Type 2 Diabetes
T2 - The Fremantle Diabetes Study
AU - Davis, Wendy A.
AU - Gregg, Edward W.
AU - Davis, Timothy M.E.
PY - 2020/7/1
Y1 - 2020/7/1
N2 - CONTEXT: There is evidence that diabetes-related complications are declining but most data sources have limitations. OBJECTIVE: To characterize temporal changes in incidence rates (IRs) of chronic complications and mortality in well-characterized, community-based Australians. DESIGN: Longitudinal observational study. SETTING: Urban population. PARTICIPANTS: Participants with type 2 diabetes from the Fremantle Diabetes Study phases I (FDS1; n = 1291 recruited 1993-1996) and II (FDS2; n = 1509 recruited 2008-2011) age-, sex,- and ZIP code-matched 1:4 to people without diabetes. MAIN OUTCOME MEASURES: First hospitalizations for/with myocardial infarction (MI), stroke, heart failure (HF), lower extremity amputation, and cardiovascular disease (CVD) and all-cause mortality. Five-year IRs, IR ratios for those with versus without diabetes in FDS1 and FDS2, and IR differences (IRDs), were calculated. RESULTS: The 13,995 participants had a mean age of 64.8 years and 50.4% were males. There were lower IR ratios for MI, stroke, HF, and CVD death in FDS2 versus FDS1. IRDs for people with versus without type 2 diabetes had reduced by >50% between phases for MI, stroke, HF, lower extremity amputation, and CVD death, with no change in IRD for all-cause mortality. Within the pooled type 2 diabetes cohort, FDS2 versus FDS1 participation was an independent inverse predictor of stroke, HF, CVD death, and all-cause mortality after adjustment in Cox proportional hazards models. CONCLUSIONS: Cardiovascular outcomes in Australians have improved since the 1990s, especially in type 2 diabetes. The difference in all-cause mortality between those with and without type 2 diabetes has persisted despite longer survival.
AB - CONTEXT: There is evidence that diabetes-related complications are declining but most data sources have limitations. OBJECTIVE: To characterize temporal changes in incidence rates (IRs) of chronic complications and mortality in well-characterized, community-based Australians. DESIGN: Longitudinal observational study. SETTING: Urban population. PARTICIPANTS: Participants with type 2 diabetes from the Fremantle Diabetes Study phases I (FDS1; n = 1291 recruited 1993-1996) and II (FDS2; n = 1509 recruited 2008-2011) age-, sex,- and ZIP code-matched 1:4 to people without diabetes. MAIN OUTCOME MEASURES: First hospitalizations for/with myocardial infarction (MI), stroke, heart failure (HF), lower extremity amputation, and cardiovascular disease (CVD) and all-cause mortality. Five-year IRs, IR ratios for those with versus without diabetes in FDS1 and FDS2, and IR differences (IRDs), were calculated. RESULTS: The 13,995 participants had a mean age of 64.8 years and 50.4% were males. There were lower IR ratios for MI, stroke, HF, and CVD death in FDS2 versus FDS1. IRDs for people with versus without type 2 diabetes had reduced by >50% between phases for MI, stroke, HF, lower extremity amputation, and CVD death, with no change in IRD for all-cause mortality. Within the pooled type 2 diabetes cohort, FDS2 versus FDS1 participation was an independent inverse predictor of stroke, HF, CVD death, and all-cause mortality after adjustment in Cox proportional hazards models. CONCLUSIONS: Cardiovascular outcomes in Australians have improved since the 1990s, especially in type 2 diabetes. The difference in all-cause mortality between those with and without type 2 diabetes has persisted despite longer survival.
KW - cardiovascular disease
KW - community-based
KW - longitudinal study
KW - mortality
KW - temporal trends
KW - type 2 diabetes
UR - http://www.scopus.com/inward/record.url?scp=85085443968&partnerID=8YFLogxK
U2 - 10.1210/clinem/dgaa215
DO - 10.1210/clinem/dgaa215
M3 - Article
C2 - 32352534
AN - SCOPUS:85085443968
SN - 0021-972X
VL - 105
JO - The Journal of clinical endocrinology and metabolism
JF - The Journal of clinical endocrinology and metabolism
IS - 7
M1 - dgaa215
ER -